Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fatigue × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Neoplasm Metastasis 3 Breast Neoplasms, Male 3 Sleep Wake Disorders 1 Ovarian Neoplasms 1 Neoplasms 1 First Line Metastatic Breast Cancer 1 Fatigue 1 Carcinoma, Intraductal, Noninfiltrating 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Advanced Breast Cancer 1

Interventions

Methylphenidate 5 Modafinil 4 Therapeutics 3 Acupuncture Therapy 3 Surveys and Questionnaires 2 Exercise 2 Counseling 2 testosterone enanthate 1 testosterone 17 beta-cypionate 1 exemestane 1 Valeriana extract 1 Triptorelin Pamoate 1 Testosterone 1 Taxes 1 Tamoxifen 1 Sugars 1 Relaxation Therapy 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Paclitaxel 1 Mental Status and Dementia Tests 1 Materia Medica 1 Infliximab 1 Hypericum extract LI 160 1 Gonadotropin-Releasing Hormone 1 Escitalopram 1 Epoetin Alfa 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡